nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosinopril—ACE—forelimb—bone cancer	0.00329	0.24	CbGeAlD
Fosinopril—ACE—hindlimb—bone cancer	0.00296	0.216	CbGeAlD
Fosinopril—ACE—arm—bone cancer	0.00283	0.206	CbGeAlD
Fosinopril—ACE—appendage—bone cancer	0.00254	0.185	CbGeAlD
Fosinopril—Pneumonia—Methotrexate—bone cancer	0.00148	0.0015	CcSEcCtD
Fosinopril—Drowsiness—Methotrexate—bone cancer	0.00147	0.00149	CcSEcCtD
Fosinopril—Pancytopenia—Epirubicin—bone cancer	0.00146	0.00149	CcSEcCtD
Fosinopril—Gastritis—Doxorubicin—bone cancer	0.00146	0.00148	CcSEcCtD
Fosinopril—Pain—Cisplatin—bone cancer	0.00146	0.00148	CcSEcCtD
Fosinopril—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.00146	0.00148	CcSEcCtD
Fosinopril—Muscular weakness—Doxorubicin—bone cancer	0.00146	0.00148	CcSEcCtD
Fosinopril—Renal failure—Methotrexate—bone cancer	0.00144	0.00146	CcSEcCtD
Fosinopril—Neutropenia—Epirubicin—bone cancer	0.00144	0.00146	CcSEcCtD
Fosinopril—Abdominal distension—Doxorubicin—bone cancer	0.00144	0.00146	CcSEcCtD
Fosinopril—Upper respiratory tract infection—Epirubicin—bone cancer	0.00143	0.00145	CcSEcCtD
Fosinopril—Asthma—Doxorubicin—bone cancer	0.00143	0.00145	CcSEcCtD
Fosinopril—Influenza—Doxorubicin—bone cancer	0.00143	0.00145	CcSEcCtD
Fosinopril—Dysphagia—Doxorubicin—bone cancer	0.00143	0.00145	CcSEcCtD
Fosinopril—Pollakiuria—Epirubicin—bone cancer	0.00142	0.00144	CcSEcCtD
Fosinopril—Eosinophilia—Doxorubicin—bone cancer	0.00141	0.00143	CcSEcCtD
Fosinopril—Photosensitivity reaction—Epirubicin—bone cancer	0.00141	0.00143	CcSEcCtD
Fosinopril—Feeling abnormal—Cisplatin—bone cancer	0.00141	0.00143	CcSEcCtD
Fosinopril—Weight increased—Epirubicin—bone cancer	0.0014	0.00142	CcSEcCtD
Fosinopril—Pancreatitis—Doxorubicin—bone cancer	0.0014	0.00142	CcSEcCtD
Fosinopril—Weight decreased—Epirubicin—bone cancer	0.0014	0.00141	CcSEcCtD
Fosinopril—Angina pectoris—Doxorubicin—bone cancer	0.00139	0.00141	CcSEcCtD
Fosinopril—Epistaxis—Methotrexate—bone cancer	0.00139	0.00141	CcSEcCtD
Fosinopril—Pneumonia—Epirubicin—bone cancer	0.00138	0.0014	CcSEcCtD
Fosinopril—Drowsiness—Epirubicin—bone cancer	0.00138	0.00139	CcSEcCtD
Fosinopril—Agranulocytosis—Methotrexate—bone cancer	0.00137	0.00139	CcSEcCtD
Fosinopril—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.00136	0.00138	CcSEcCtD
Fosinopril—Pancytopenia—Doxorubicin—bone cancer	0.00136	0.00137	CcSEcCtD
Fosinopril—Renal failure—Epirubicin—bone cancer	0.00135	0.00137	CcSEcCtD
Fosinopril—Body temperature increased—Cisplatin—bone cancer	0.00135	0.00137	CcSEcCtD
Fosinopril—Neuropathy peripheral—Epirubicin—bone cancer	0.00135	0.00137	CcSEcCtD
Fosinopril—Jaundice—Epirubicin—bone cancer	0.00134	0.00136	CcSEcCtD
Fosinopril—Neutropenia—Doxorubicin—bone cancer	0.00133	0.00135	CcSEcCtD
Fosinopril—Upper respiratory tract infection—Doxorubicin—bone cancer	0.00133	0.00134	CcSEcCtD
Fosinopril—Haemoglobin—Methotrexate—bone cancer	0.00133	0.00134	CcSEcCtD
Fosinopril—Haemorrhage—Methotrexate—bone cancer	0.00132	0.00134	CcSEcCtD
Fosinopril—Hepatitis—Methotrexate—bone cancer	0.00132	0.00134	CcSEcCtD
Fosinopril—Pollakiuria—Doxorubicin—bone cancer	0.00132	0.00134	CcSEcCtD
Fosinopril—Pharyngitis—Methotrexate—bone cancer	0.00131	0.00133	CcSEcCtD
Fosinopril—Photosensitivity reaction—Doxorubicin—bone cancer	0.0013	0.00132	CcSEcCtD
Fosinopril—Weight increased—Doxorubicin—bone cancer	0.0013	0.00132	CcSEcCtD
Fosinopril—Epistaxis—Epirubicin—bone cancer	0.0013	0.00132	CcSEcCtD
Fosinopril—Weight decreased—Doxorubicin—bone cancer	0.00129	0.00131	CcSEcCtD
Fosinopril—Sinusitis—Epirubicin—bone cancer	0.00129	0.00131	CcSEcCtD
Fosinopril—Agranulocytosis—Epirubicin—bone cancer	0.00128	0.0013	CcSEcCtD
Fosinopril—Pneumonia—Doxorubicin—bone cancer	0.00128	0.0013	CcSEcCtD
Fosinopril—Drowsiness—Doxorubicin—bone cancer	0.00127	0.00129	CcSEcCtD
Fosinopril—Visual impairment—Methotrexate—bone cancer	0.00127	0.00129	CcSEcCtD
Fosinopril—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.00126	0.00128	CcSEcCtD
Fosinopril—Hypersensitivity—Cisplatin—bone cancer	0.00126	0.00128	CcSEcCtD
Fosinopril—Bradycardia—Epirubicin—bone cancer	0.00126	0.00127	CcSEcCtD
Fosinopril—Renal failure—Doxorubicin—bone cancer	0.00125	0.00127	CcSEcCtD
Fosinopril—Erythema multiforme—Methotrexate—bone cancer	0.00125	0.00126	CcSEcCtD
Fosinopril—Neuropathy peripheral—Doxorubicin—bone cancer	0.00125	0.00126	CcSEcCtD
Fosinopril—Haemoglobin—Epirubicin—bone cancer	0.00124	0.00126	CcSEcCtD
Fosinopril—Jaundice—Doxorubicin—bone cancer	0.00124	0.00126	CcSEcCtD
Fosinopril—Rhinitis—Epirubicin—bone cancer	0.00124	0.00125	CcSEcCtD
Fosinopril—Hepatitis—Epirubicin—bone cancer	0.00123	0.00125	CcSEcCtD
Fosinopril—Haemorrhage—Epirubicin—bone cancer	0.00123	0.00125	CcSEcCtD
Fosinopril—Tinnitus—Methotrexate—bone cancer	0.00123	0.00125	CcSEcCtD
Fosinopril—Hypoaesthesia—Epirubicin—bone cancer	0.00123	0.00125	CcSEcCtD
Fosinopril—Asthenia—Cisplatin—bone cancer	0.00123	0.00124	CcSEcCtD
Fosinopril—Pharyngitis—Epirubicin—bone cancer	0.00123	0.00124	CcSEcCtD
Fosinopril—Oedema peripheral—Epirubicin—bone cancer	0.00122	0.00123	CcSEcCtD
Fosinopril—Epistaxis—Doxorubicin—bone cancer	0.0012	0.00122	CcSEcCtD
Fosinopril—Sinusitis—Doxorubicin—bone cancer	0.00119	0.00121	CcSEcCtD
Fosinopril—Visual impairment—Epirubicin—bone cancer	0.00119	0.00121	CcSEcCtD
Fosinopril—Agranulocytosis—Doxorubicin—bone cancer	0.00119	0.0012	CcSEcCtD
Fosinopril—Chills—Methotrexate—bone cancer	0.00118	0.0012	CcSEcCtD
Fosinopril—Diarrhoea—Cisplatin—bone cancer	0.00117	0.00118	CcSEcCtD
Fosinopril—Erythema multiforme—Epirubicin—bone cancer	0.00117	0.00118	CcSEcCtD
Fosinopril—Bradycardia—Doxorubicin—bone cancer	0.00116	0.00118	CcSEcCtD
Fosinopril—Tinnitus—Epirubicin—bone cancer	0.00115	0.00117	CcSEcCtD
Fosinopril—Haemoglobin—Doxorubicin—bone cancer	0.00115	0.00116	CcSEcCtD
Fosinopril—Flushing—Epirubicin—bone cancer	0.00115	0.00116	CcSEcCtD
Fosinopril—Rhinitis—Doxorubicin—bone cancer	0.00115	0.00116	CcSEcCtD
Fosinopril—Haemorrhage—Doxorubicin—bone cancer	0.00114	0.00116	CcSEcCtD
Fosinopril—Hepatitis—Doxorubicin—bone cancer	0.00114	0.00116	CcSEcCtD
Fosinopril—Hypoaesthesia—Doxorubicin—bone cancer	0.00114	0.00115	CcSEcCtD
Fosinopril—Pharyngitis—Doxorubicin—bone cancer	0.00113	0.00115	CcSEcCtD
Fosinopril—Oedema peripheral—Doxorubicin—bone cancer	0.00113	0.00114	CcSEcCtD
Fosinopril—Dysgeusia—Methotrexate—bone cancer	0.00112	0.00114	CcSEcCtD
Fosinopril—Chills—Epirubicin—bone cancer	0.00111	0.00112	CcSEcCtD
Fosinopril—Arrhythmia—Epirubicin—bone cancer	0.0011	0.00112	CcSEcCtD
Fosinopril—Visual impairment—Doxorubicin—bone cancer	0.0011	0.00112	CcSEcCtD
Fosinopril—Vomiting—Cisplatin—bone cancer	0.00109	0.0011	CcSEcCtD
Fosinopril—Vision blurred—Methotrexate—bone cancer	0.00108	0.0011	CcSEcCtD
Fosinopril—Erythema multiforme—Doxorubicin—bone cancer	0.00108	0.0011	CcSEcCtD
Fosinopril—Rash—Cisplatin—bone cancer	0.00108	0.00109	CcSEcCtD
Fosinopril—Dermatitis—Cisplatin—bone cancer	0.00108	0.00109	CcSEcCtD
Fosinopril—Ill-defined disorder—Methotrexate—bone cancer	0.00107	0.00108	CcSEcCtD
Fosinopril—Tinnitus—Doxorubicin—bone cancer	0.00107	0.00108	CcSEcCtD
Fosinopril—Anaemia—Methotrexate—bone cancer	0.00106	0.00108	CcSEcCtD
Fosinopril—Flushing—Doxorubicin—bone cancer	0.00106	0.00107	CcSEcCtD
Fosinopril—Flatulence—Epirubicin—bone cancer	0.00106	0.00107	CcSEcCtD
Fosinopril—Tension—Epirubicin—bone cancer	0.00105	0.00107	CcSEcCtD
Fosinopril—Dysgeusia—Epirubicin—bone cancer	0.00105	0.00107	CcSEcCtD
Fosinopril—Nervousness—Epirubicin—bone cancer	0.00104	0.00106	CcSEcCtD
Fosinopril—Malaise—Methotrexate—bone cancer	0.00104	0.00105	CcSEcCtD
Fosinopril—Muscle spasms—Epirubicin—bone cancer	0.00103	0.00105	CcSEcCtD
Fosinopril—Vertigo—Methotrexate—bone cancer	0.00103	0.00105	CcSEcCtD
Fosinopril—Leukopenia—Methotrexate—bone cancer	0.00103	0.00104	CcSEcCtD
Fosinopril—Chills—Doxorubicin—bone cancer	0.00102	0.00104	CcSEcCtD
Fosinopril—Arrhythmia—Doxorubicin—bone cancer	0.00102	0.00103	CcSEcCtD
Fosinopril—Nausea—Cisplatin—bone cancer	0.00101	0.00103	CcSEcCtD
Fosinopril—Vision blurred—Epirubicin—bone cancer	0.00101	0.00103	CcSEcCtD
Fosinopril—Cough—Methotrexate—bone cancer	0.001	0.00102	CcSEcCtD
Fosinopril—Ill-defined disorder—Epirubicin—bone cancer	0.000997	0.00101	CcSEcCtD
Fosinopril—Anaemia—Epirubicin—bone cancer	0.000993	0.00101	CcSEcCtD
Fosinopril—Agitation—Epirubicin—bone cancer	0.000988	0.001	CcSEcCtD
Fosinopril—Flatulence—Doxorubicin—bone cancer	0.00098	0.000993	CcSEcCtD
Fosinopril—Arthralgia—Methotrexate—bone cancer	0.000978	0.000991	CcSEcCtD
Fosinopril—Myalgia—Methotrexate—bone cancer	0.000978	0.000991	CcSEcCtD
Fosinopril—Chest pain—Methotrexate—bone cancer	0.000978	0.000991	CcSEcCtD
Fosinopril—Tension—Doxorubicin—bone cancer	0.000976	0.000989	CcSEcCtD
Fosinopril—Dysgeusia—Doxorubicin—bone cancer	0.000974	0.000987	CcSEcCtD
Fosinopril—Malaise—Epirubicin—bone cancer	0.000969	0.000983	CcSEcCtD
Fosinopril—Discomfort—Methotrexate—bone cancer	0.000966	0.000979	CcSEcCtD
Fosinopril—Nervousness—Doxorubicin—bone cancer	0.000966	0.000979	CcSEcCtD
Fosinopril—Vertigo—Epirubicin—bone cancer	0.000966	0.000979	CcSEcCtD
Fosinopril—Syncope—Epirubicin—bone cancer	0.000964	0.000977	CcSEcCtD
Fosinopril—Leukopenia—Epirubicin—bone cancer	0.000962	0.000975	CcSEcCtD
Fosinopril—Muscle spasms—Doxorubicin—bone cancer	0.000956	0.000969	CcSEcCtD
Fosinopril—Palpitations—Epirubicin—bone cancer	0.00095	0.000963	CcSEcCtD
Fosinopril—Confusional state—Methotrexate—bone cancer	0.000945	0.000958	CcSEcCtD
Fosinopril—Loss of consciousness—Epirubicin—bone cancer	0.000945	0.000958	CcSEcCtD
Fosinopril—Cough—Epirubicin—bone cancer	0.000938	0.000951	CcSEcCtD
Fosinopril—Anaphylactic shock—Methotrexate—bone cancer	0.000937	0.00095	CcSEcCtD
Fosinopril—Vision blurred—Doxorubicin—bone cancer	0.000937	0.00095	CcSEcCtD
Fosinopril—Infection—Methotrexate—bone cancer	0.000931	0.000944	CcSEcCtD
Fosinopril—Hypertension—Epirubicin—bone cancer	0.000928	0.000941	CcSEcCtD
Fosinopril—Ill-defined disorder—Doxorubicin—bone cancer	0.000923	0.000935	CcSEcCtD
Fosinopril—Anaemia—Doxorubicin—bone cancer	0.000919	0.000932	CcSEcCtD
Fosinopril—Thrombocytopenia—Methotrexate—bone cancer	0.000918	0.00093	CcSEcCtD
Fosinopril—Chest pain—Epirubicin—bone cancer	0.000915	0.000928	CcSEcCtD
Fosinopril—Arthralgia—Epirubicin—bone cancer	0.000915	0.000928	CcSEcCtD
Fosinopril—Myalgia—Epirubicin—bone cancer	0.000915	0.000928	CcSEcCtD
Fosinopril—Agitation—Doxorubicin—bone cancer	0.000914	0.000927	CcSEcCtD
Fosinopril—Hyperhidrosis—Methotrexate—bone cancer	0.000906	0.000919	CcSEcCtD
Fosinopril—Discomfort—Epirubicin—bone cancer	0.000904	0.000917	CcSEcCtD
Fosinopril—Malaise—Doxorubicin—bone cancer	0.000897	0.000909	CcSEcCtD
Fosinopril—Dry mouth—Epirubicin—bone cancer	0.000895	0.000907	CcSEcCtD
Fosinopril—Vertigo—Doxorubicin—bone cancer	0.000893	0.000906	CcSEcCtD
Fosinopril—Anorexia—Methotrexate—bone cancer	0.000893	0.000906	CcSEcCtD
Fosinopril—Syncope—Doxorubicin—bone cancer	0.000892	0.000904	CcSEcCtD
Fosinopril—Leukopenia—Doxorubicin—bone cancer	0.00089	0.000902	CcSEcCtD
Fosinopril—Confusional state—Epirubicin—bone cancer	0.000884	0.000897	CcSEcCtD
Fosinopril—Palpitations—Doxorubicin—bone cancer	0.000879	0.000891	CcSEcCtD
Fosinopril—Anaphylactic shock—Epirubicin—bone cancer	0.000877	0.000889	CcSEcCtD
Fosinopril—Oedema—Epirubicin—bone cancer	0.000877	0.000889	CcSEcCtD
Fosinopril—Hypotension—Methotrexate—bone cancer	0.000876	0.000888	CcSEcCtD
Fosinopril—Loss of consciousness—Doxorubicin—bone cancer	0.000874	0.000886	CcSEcCtD
Fosinopril—Infection—Epirubicin—bone cancer	0.000871	0.000883	CcSEcCtD
Fosinopril—Cough—Doxorubicin—bone cancer	0.000868	0.00088	CcSEcCtD
Fosinopril—Shock—Epirubicin—bone cancer	0.000863	0.000875	CcSEcCtD
Fosinopril—Thrombocytopenia—Epirubicin—bone cancer	0.000859	0.000871	CcSEcCtD
Fosinopril—Hypertension—Doxorubicin—bone cancer	0.000858	0.00087	CcSEcCtD
Fosinopril—Tachycardia—Epirubicin—bone cancer	0.000856	0.000868	CcSEcCtD
Fosinopril—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000854	0.000866	CcSEcCtD
Fosinopril—Hyperhidrosis—Epirubicin—bone cancer	0.000848	0.00086	CcSEcCtD
Fosinopril—Insomnia—Methotrexate—bone cancer	0.000848	0.000859	CcSEcCtD
Fosinopril—Arthralgia—Doxorubicin—bone cancer	0.000847	0.000858	CcSEcCtD
Fosinopril—Myalgia—Doxorubicin—bone cancer	0.000847	0.000858	CcSEcCtD
Fosinopril—Chest pain—Doxorubicin—bone cancer	0.000847	0.000858	CcSEcCtD
Fosinopril—Paraesthesia—Methotrexate—bone cancer	0.000842	0.000853	CcSEcCtD
Fosinopril—Discomfort—Doxorubicin—bone cancer	0.000836	0.000848	CcSEcCtD
Fosinopril—Anorexia—Epirubicin—bone cancer	0.000836	0.000848	CcSEcCtD
Fosinopril—Dyspnoea—Methotrexate—bone cancer	0.000836	0.000847	CcSEcCtD
Fosinopril—Somnolence—Methotrexate—bone cancer	0.000833	0.000845	CcSEcCtD
Fosinopril—Dry mouth—Doxorubicin—bone cancer	0.000828	0.000839	CcSEcCtD
Fosinopril—Dyspepsia—Methotrexate—bone cancer	0.000825	0.000836	CcSEcCtD
Fosinopril—Hypotension—Epirubicin—bone cancer	0.00082	0.000831	CcSEcCtD
Fosinopril—Confusional state—Doxorubicin—bone cancer	0.000818	0.00083	CcSEcCtD
Fosinopril—Decreased appetite—Methotrexate—bone cancer	0.000815	0.000826	CcSEcCtD
Fosinopril—Anaphylactic shock—Doxorubicin—bone cancer	0.000812	0.000823	CcSEcCtD
Fosinopril—Oedema—Doxorubicin—bone cancer	0.000812	0.000823	CcSEcCtD
Fosinopril—Fatigue—Methotrexate—bone cancer	0.000808	0.000819	CcSEcCtD
Fosinopril—Infection—Doxorubicin—bone cancer	0.000806	0.000817	CcSEcCtD
Fosinopril—Pain—Methotrexate—bone cancer	0.000801	0.000813	CcSEcCtD
Fosinopril—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000799	0.00081	CcSEcCtD
Fosinopril—Shock—Doxorubicin—bone cancer	0.000798	0.00081	CcSEcCtD
Fosinopril—Thrombocytopenia—Doxorubicin—bone cancer	0.000795	0.000806	CcSEcCtD
Fosinopril—Insomnia—Epirubicin—bone cancer	0.000793	0.000804	CcSEcCtD
Fosinopril—Tachycardia—Doxorubicin—bone cancer	0.000792	0.000803	CcSEcCtD
Fosinopril—Paraesthesia—Epirubicin—bone cancer	0.000788	0.000799	CcSEcCtD
Fosinopril—Hyperhidrosis—Doxorubicin—bone cancer	0.000785	0.000795	CcSEcCtD
Fosinopril—Dyspnoea—Epirubicin—bone cancer	0.000782	0.000793	CcSEcCtD
Fosinopril—Somnolence—Epirubicin—bone cancer	0.00078	0.000791	CcSEcCtD
Fosinopril—Anorexia—Doxorubicin—bone cancer	0.000774	0.000784	CcSEcCtD
Fosinopril—Feeling abnormal—Methotrexate—bone cancer	0.000772	0.000783	CcSEcCtD
Fosinopril—Dyspepsia—Epirubicin—bone cancer	0.000772	0.000783	CcSEcCtD
Fosinopril—Gastrointestinal pain—Methotrexate—bone cancer	0.000766	0.000777	CcSEcCtD
Fosinopril—Decreased appetite—Epirubicin—bone cancer	0.000762	0.000773	CcSEcCtD
Fosinopril—Hypotension—Doxorubicin—bone cancer	0.000758	0.000769	CcSEcCtD
Fosinopril—Fatigue—Epirubicin—bone cancer	0.000756	0.000767	CcSEcCtD
Fosinopril—Pain—Epirubicin—bone cancer	0.00075	0.00076	CcSEcCtD
Fosinopril—Constipation—Epirubicin—bone cancer	0.00075	0.00076	CcSEcCtD
Fosinopril—Urticaria—Methotrexate—bone cancer	0.000745	0.000755	CcSEcCtD
Fosinopril—Abdominal pain—Methotrexate—bone cancer	0.000741	0.000751	CcSEcCtD
Fosinopril—Body temperature increased—Methotrexate—bone cancer	0.000741	0.000751	CcSEcCtD
Fosinopril—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000739	0.00075	CcSEcCtD
Fosinopril—Insomnia—Doxorubicin—bone cancer	0.000734	0.000744	CcSEcCtD
Fosinopril—Paraesthesia—Doxorubicin—bone cancer	0.000729	0.000739	CcSEcCtD
Fosinopril—ACE—connective tissue—bone cancer	0.000725	0.0528	CbGeAlD
Fosinopril—Dyspnoea—Doxorubicin—bone cancer	0.000724	0.000734	CcSEcCtD
Fosinopril—Feeling abnormal—Epirubicin—bone cancer	0.000723	0.000733	CcSEcCtD
Fosinopril—Somnolence—Doxorubicin—bone cancer	0.000721	0.000732	CcSEcCtD
Fosinopril—Gastrointestinal pain—Epirubicin—bone cancer	0.000717	0.000727	CcSEcCtD
Fosinopril—Dyspepsia—Doxorubicin—bone cancer	0.000714	0.000724	CcSEcCtD
Fosinopril—Decreased appetite—Doxorubicin—bone cancer	0.000705	0.000715	CcSEcCtD
Fosinopril—Fatigue—Doxorubicin—bone cancer	0.0007	0.000709	CcSEcCtD
Fosinopril—Urticaria—Epirubicin—bone cancer	0.000697	0.000706	CcSEcCtD
Fosinopril—Pain—Doxorubicin—bone cancer	0.000694	0.000704	CcSEcCtD
Fosinopril—Constipation—Doxorubicin—bone cancer	0.000694	0.000704	CcSEcCtD
Fosinopril—Body temperature increased—Epirubicin—bone cancer	0.000693	0.000703	CcSEcCtD
Fosinopril—Abdominal pain—Epirubicin—bone cancer	0.000693	0.000703	CcSEcCtD
Fosinopril—Hypersensitivity—Methotrexate—bone cancer	0.00069	0.0007	CcSEcCtD
Fosinopril—Asthenia—Methotrexate—bone cancer	0.000672	0.000682	CcSEcCtD
Fosinopril—Feeling abnormal—Doxorubicin—bone cancer	0.000669	0.000678	CcSEcCtD
Fosinopril—Gastrointestinal pain—Doxorubicin—bone cancer	0.000664	0.000673	CcSEcCtD
Fosinopril—Pruritus—Methotrexate—bone cancer	0.000663	0.000672	CcSEcCtD
Fosinopril—Hypersensitivity—Epirubicin—bone cancer	0.000646	0.000655	CcSEcCtD
Fosinopril—Urticaria—Doxorubicin—bone cancer	0.000645	0.000654	CcSEcCtD
Fosinopril—Abdominal pain—Doxorubicin—bone cancer	0.000642	0.00065	CcSEcCtD
Fosinopril—Body temperature increased—Doxorubicin—bone cancer	0.000642	0.00065	CcSEcCtD
Fosinopril—Diarrhoea—Methotrexate—bone cancer	0.000641	0.00065	CcSEcCtD
Fosinopril—Asthenia—Epirubicin—bone cancer	0.000629	0.000638	CcSEcCtD
Fosinopril—Pruritus—Epirubicin—bone cancer	0.000621	0.000629	CcSEcCtD
Fosinopril—Dizziness—Methotrexate—bone cancer	0.00062	0.000628	CcSEcCtD
Fosinopril—Diarrhoea—Epirubicin—bone cancer	0.0006	0.000608	CcSEcCtD
Fosinopril—Hypersensitivity—Doxorubicin—bone cancer	0.000598	0.000606	CcSEcCtD
Fosinopril—Vomiting—Methotrexate—bone cancer	0.000596	0.000604	CcSEcCtD
Fosinopril—Rash—Methotrexate—bone cancer	0.000591	0.000599	CcSEcCtD
Fosinopril—Dermatitis—Methotrexate—bone cancer	0.00059	0.000599	CcSEcCtD
Fosinopril—Headache—Methotrexate—bone cancer	0.000587	0.000595	CcSEcCtD
Fosinopril—Asthenia—Doxorubicin—bone cancer	0.000582	0.00059	CcSEcCtD
Fosinopril—Dizziness—Epirubicin—bone cancer	0.00058	0.000588	CcSEcCtD
Fosinopril—Pruritus—Doxorubicin—bone cancer	0.000574	0.000582	CcSEcCtD
Fosinopril—Vomiting—Epirubicin—bone cancer	0.000558	0.000565	CcSEcCtD
Fosinopril—Nausea—Methotrexate—bone cancer	0.000557	0.000564	CcSEcCtD
Fosinopril—Diarrhoea—Doxorubicin—bone cancer	0.000555	0.000563	CcSEcCtD
Fosinopril—Rash—Epirubicin—bone cancer	0.000553	0.000561	CcSEcCtD
Fosinopril—Dermatitis—Epirubicin—bone cancer	0.000552	0.00056	CcSEcCtD
Fosinopril—Headache—Epirubicin—bone cancer	0.000549	0.000557	CcSEcCtD
Fosinopril—Dizziness—Doxorubicin—bone cancer	0.000537	0.000544	CcSEcCtD
Fosinopril—Nausea—Epirubicin—bone cancer	0.000521	0.000528	CcSEcCtD
Fosinopril—Vomiting—Doxorubicin—bone cancer	0.000516	0.000523	CcSEcCtD
Fosinopril—Rash—Doxorubicin—bone cancer	0.000512	0.000519	CcSEcCtD
Fosinopril—Dermatitis—Doxorubicin—bone cancer	0.000511	0.000518	CcSEcCtD
Fosinopril—Headache—Doxorubicin—bone cancer	0.000508	0.000515	CcSEcCtD
Fosinopril—ACE—bone marrow—bone cancer	0.000483	0.0352	CbGeAlD
Fosinopril—Nausea—Doxorubicin—bone cancer	0.000482	0.000489	CcSEcCtD
Fosinopril—ACE—spinal cord—bone cancer	0.000481	0.035	CbGeAlD
Fosinopril—SLC15A2—spinal cord—bone cancer	0.000419	0.0305	CbGeAlD
